Form 483

Intas Pharmaceuticals Limited Form 483, 2023-05-12

FDA issued a Form 483 to Intas Pharmaceuticals Limited on 2023-05-12 with 16 public-safe observations.

483· Form 483 issuedHuman Drugs16 observations

Intas Pharmaceuticals Limited · Ahmedabad, India · Issued May 12, 2023

Overview

  • 16 public-safe observations are available for this inspection.
  • 16 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 May 2023
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Justin A Boyd, Rita K Kabaso, Arsen Karapetyan, Rita K Vick

12 May 2023
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Justin A Boyd, Rita K Kabaso, Arsen Karapetyan, Rita K Vick

12 May 2023
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Justin A Boyd, Rita K Kabaso, Arsen Karapetyan, Rita K Vick

12 May 2023
21 CFR 211.165(e)

Test methods

Cited by Justin A Boyd, Rita K Kabaso, Arsen Karapetyan, Rita K Vick

12 May 2023
21 CFR 211.180(e)(1)

Representative Number of Batches for Annual Review

Cited by Justin A Boyd, Rita K Kabaso, Arsen Karapetyan, Rita K Vick

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 16 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere